See also this year's filing and all EDGAR filings for this company.
PDF Report 0001517022_2023_Akebia_Therapeutics_Inc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001517022, Akebia Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 184,949,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 55,053,000 |
| 2 | PropertyPlantAndEquipmentNet | 5,214,000 |
| 3 | remainder_Assets | 106,614,000 |
| 4 | LiabilitiesCurrent | 124,756,000 |
| 5 | LiabilitiesNoncurrent | 118,496,000 |
| 6 | remainder_Liabilities | 99,236,000 |
| 7 | CostOfGoodsAndServicesSold | 84,796,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 138,699,000 |
| 9 | ResearchAndDevelopmentExpense | 129,114,000 |
| 10 | remainder_Expenses | 19,108,000 |
| 11 | remainder_Revenues | 292,602,000 |
| 12 | remainder_NetIncome | -13,447,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 351,830,000 |
| 1 | Liabilities | 342,488,000 |
| 2 | Expenses | 371,717,000 |
| 3 | Revenues | 292,602,000 |
| 4 | StockholdersEquity | 9,342,000 |
| 5 | NetIncome | -92,562,000 |
| 6 | ComprehensiveNetIncome | -92,562,000 |
| 7 | BaseVar | 686,042,000 |
| 8 | EconomicCapitalRatio | -0.220 |
Edgar->Model Mapping
Feature Distribution
Change over Time
